Your Search Returned 144 tagged news reports
Sivida Iluvien available in Germany pSivida has announced the availability of the sustained release pharmaceutical product indicated for the treatment of chronic diabetic macular edema (DME), Iluvien, in Germany...Alimera as well as 20% of net
Tags:
S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in
Tags:
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector. FDA panel reviews/findings provided the impetus for some big moves; however, that was only part of the story. Four other biotech companies released clinical-
Tags:
Horrendous Health-Care Stocks This Week Don't let it get away!...That's the common denominator on this week's list of horrendous performers in health care.\: They all had disappointments of one type or another. Here they are -- three of the worst
Tags:
Can't-Miss FDA Actions This Week Watch stocks you care about The single, easiest way to keep track of all the stocks that matter.....Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the
Tags:
The late afternoon rally of the Dow Jones Industrial Average is becoming a routine occurrence. The index once again started off down from its previous close, only to gain slowly throughout the day and then rally toward the close, yesterday gaining 48
Tags:
Normally, our weekly look at what's going on within the health-care sectors involves a mixture of health-care conferences, FDA panel meetings and decisions, and a plethora of earnings reports. However, as we work our way into a holiday-shortened week
Tags:
Can't-Miss Health-Care Events This Week Don't let it get away!...FDA panel meetings and two earnings reports that simply can't be missed...As TheStreet.com's Aafia Chaudrey noted in early February , DepoMed's first two Breeze trials were largely
Tags:
has concluded the repurchase of warrants it issued to the Treasury Department during the financial crisis. This removes the final element of government involvement in the company. The warrants, which were sold in two tranches in 2008 and 2009, were
Tags:
using a proprietary parenteral drug delivery system Medi-Jet technology. Medi-Jet enables patients to self-administer a drug subcutaneously or intramuscularly, while also enhancing safety with an integrated, shielded needle that protects against
Tags: